Developing safe and effective therapeutics requires rigorous preclinical safety evaluation. At Toxicology-IND.com, we specialize in comprehensive toxicology testing services designed to support Investigational New Drug (IND) applications and advance your compounds toward clinical trials with confidence. Our focus is on delivering scientifically robust data aligned with international regulatory standards to accelerate drug development.
Comprehensive Toxicology Testing for Regulatory Compliance
We conduct a wide range of toxicology studies critical for IND submissions, including acute toxicity, subchronic and chronic toxicity, carcinogenicity, and toxicokinetic analyses. We follow OECD guidelines and Good Laboratory Practice (GLP) standards to ensure data integrity and regulatory acceptance worldwide. Whether you need dermal, inhalation, oral, or systemic toxicity assessments, our team provides tailored study designs and expert execution.
Expertise in OECD-Compliant Toxicology Studies
We conduct toxicity studies in strict accordance with internationally recognized OECD guidelines to ensure regulatory compliance and data reliability. Our expertise covers a comprehensive range of protocols including OECD 402 (Acute Dermal Toxicity), OECD 403 (Acute Inhalation Toxicity), OECD 404 (Acute Dermal Irritation), OECD 408 (Subchronic Oral Toxicity), OECD 417 (Toxicokinetics), OECD 425 (Acute Toxicology Dose Range Finding), OECD 452 (Chronic Toxicity), and OECD 453 (Carcinogenicity). Each study is designed and executed with rigorous adherence to Good Laboratory Practice (GLP) standards, integrating classical toxicological endpoints with advanced analytical and histopathological assessments to provide a complete safety profile tailored to your IND-enabling needs.
Specialized Services for IND-Enabling Studies
Beyond standard toxicity testing, we offer specialized services including dose range finding, dermal irritation testing, chronic toxicity studies, and mechanistic toxicology assessments. Our capabilities extend to reproductive toxicity screening and immunotoxicity evaluation, helping you address key regulatory questions early in development.